1) anti-tubercular fixed-dose combination
抗结核四联药物
2) Anti-tuberculosis drugs
抗结核药物
1.
Side effects of anti-tuberculosis drugs in 156 spinal tuberculosis patients
156例脊柱结核患者抗结核药物副作用临床分析
2.
Objective To observe whether the reductive glutathione have protection action for liver injuy induced by anti-tuberculosis drugs.
目的 观察还原型谷胱甘肽对抗结核药物所致肝损害是否具有保护作用。
3.
Objective:To explore the liver damage induced by anti-tuberculosis drugs,and to identify certain regulations and control measures.
目的:探讨抗结核药物对肝脏损害的特点和防治办法。
3) antituberculotic
抗结核药物
1.
Objective To observe the liver damage by antituberculotic in the short-period treatment.
目的观察抗结核药物短程化疗对肝功能的损害情况。
5) Antitubercular drugs
抗结核药物
1.
METHODS The patients in the therapeutic group took Tioprooin orally and had administration of antitubercular drugs,while those in the control group used antitubercular drugs only.
方法 观察组采用凯西莱口服与抗结核药物治疗结核病 ,抗结核方案为 2HSRZ/ 4HRZ。
6) Antituberculosis drug
抗结核药物
1.
The effect of antituberculosis drugs on liver functions of patients suffered with pulmonary tuberculosis and type B hepatitis
抗结核药物对肺结核合并乙肝患者肝功能的影响
2.
Objective To analyze the epidemical characteristics of the antituberculosis drug-induced liver injury.
目的分析抗结核药物诱导的肝损伤的临床情况。
补充资料:抗代谢类抗肿瘤药物
抗代谢类抗肿瘤药物
antimetabolite agents
此类抗癌药对核酸代谢物与酶结合反应有相互竞争作用,影响与阻断了核酸的合成,如氟尿嘧啶、甲氨蝶呤、呋喃氟尿嘧啶、阿糖胞苷等。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条